Human prostate cancer cells (DU145) treated with Ad‐ZF‐Dnmt3aC‐1C showed significant reduction in PD‐L1 expression as compared to Ad‐ZF‐Dnmt3aC or Ad‐ZF‐Dnmt1C alone. Here, CD274 is linked to prostate carcinoma.